These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6215132)

  • 1. [Secondary prevention of Down's syndrome in Czechoslovakia 1975-1980].
    Kucera J
    Cesk Pediatr; 1982 Jul; 37(7):404-8. PubMed ID: 6215132
    [No Abstract]   [Full Text] [Related]  

  • 2. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary prevention of Down's syndrome in Czechoslovakia 1975-1975].
    Kucera J; Pelesková A
    Cesk Gynekol; 1985 Mar; 50(2):128-32. PubMed ID: 3159486
    [No Abstract]   [Full Text] [Related]  

  • 4. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-benefit analysis of the prevention of Down's syndrome by means of prenatal diagnosis during early pregnancy].
    Flatz VG
    Fortschr Med; 1978 Jun; 96(24):1255-6, 1295. PubMed ID: 149085
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for Down's syndrome. Data do not support study's claim.
    Norgaard-Pedersen B
    BMJ; 2000 Sep; 321(7263):763; author reply 764-5. PubMed ID: 10999925
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: The prevention of Down's syndrome.
    Stein Z; Polkes AV
    Ann Clin Res; 1973 Apr; 5(2):65-7. PubMed ID: 4270653
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of induced abortion on the incidence of Down's syndrome in Hawaii.
    Smith RG; Gardner RW; Steinhoff P; Chung CS; Palmore JA
    Fam Plann Perspect; 1980; 12(4):201-5. PubMed ID: 6449372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What you need to know about... Down's syndrome.
    Nurs Times; 2003 Jun 3-9; 99(22):28. PubMed ID: 12808746
    [No Abstract]   [Full Text] [Related]  

  • 10. Down syndrome prevention program in a population with an older maternal age.
    Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
    Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V; Moatti JP; Muller F; Le Galès C; Boué A
    Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prenatal genetic diagnosis and Down's syndrome].
    Srsen S; Srsnová K
    Cesk Gynekol; 1986 May; 51(4):271-4. PubMed ID: 2941168
    [No Abstract]   [Full Text] [Related]  

  • 13. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for Down's syndrome in the 2d trimester of pregnancy: initial results].
    Stejskal D
    Cesk Gynekol; 1993 Feb; 58(1):5-10. PubMed ID: 8319282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Down syndrome: the Jerusalem experience.
    Bach G; Ben-Neriah Z; Sagi M
    Isr J Med Sci; 1993 Aug; 29(8):468-70. PubMed ID: 7691779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prenatal diagnosis of Down's syndrome: prediction from maternal serum markers].
    Zilberstein T; Maymon E
    Harefuah; 1998 Mar; 134(5):393-6. PubMed ID: 10909560
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors in a woman's decision to undergo genetic amniocentesis for advanced maternal age.
    Davies BL; Doran TA
    Nurs Res; 1982; 31(1):56-9. PubMed ID: 6214766
    [No Abstract]   [Full Text] [Related]  

  • 18. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood screening for Down's syndrome in women under 35 years of age with an age-independent index].
    Benz R; Müller U; Krahner-Pilat M; Wagner-Geuder S; Terinde R
    Z Geburtshilfe Perinatol; 1993; 197(5):205-8. PubMed ID: 7505992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.